Dear patients,

During the SARS-CoV-2 pandemic, we have been trying to understand whether patients with rare liver diseases are at higher risk of suffering a severe course of COVID-19.
Britta Zecher published a Europe-wide patient-oriented survey and found a low rate of COVID-19 in patients with autoimmune liver disease (AIH), suggesting that patients with AIH are not at increased risk of COVID-19 (https://doi.org/10.1002/ueg2.12100).

To get a broader overview of the situation of patients with AIH, we have created an anonymous and patient-oriented online survey in several languages for patients with AIH.

We would be pleased if you as an AIH patient could support us with your answers to the survey. The following link will take you to the survey (the language can be changed via the “Languages” drop-down list on the right-hand side):
https://ec.europa.eu/eusurvey/runner/followup_aild_covid

The survey will be online until 30 September 2022.

The ERN RARE-LIVER Office Team